Invenia Insights | March 2025
Invenia Group
Global Talent & Executive Search Specialists to the Pharma, Scientific Process & Technology, and Medical Device markets
Welcome back to Invenia Insights!
In this edition of our monthly newsletter, we aim to deliver valuable insights from the life science, medtech and biopharma markets, straight to your inbox.
We’ve had a busy month this March, with 3 of our consultants attending 3 different conferences abroad. Tanya Ridding & James Chippindale flew to California to attend LSI, catching up with clients and candidates and engaging with some of the greatest minds in the MedTech market. Revna Cömertpay flew to Belgium & France to attend both Laborama and ForumLabo events, taking in some of the latest and most innovative technologies across the life science industry.
Let’s dive into some of our trending content this month:
MedTech & HealthTech
Top tips for CEOs when taking over as a non-founder of a startup company
Taking over as a CEO from a Founder is often a herculean task, especially when you’re succeeding founders who have invested their money, time, passion, and life into the business. We offer tips for stepping into this role:
Explore more here: https://shorturl.at/MUqTl
6 top tips for creating a stand-out startup company
The path to a successful exit is seldom in a straight line. In the face of intense competition, creating a startup that stands out from the crowd is a challenge; positioning it for a successful exit is even more so. Tanya repurposes Scott Nelson, CEO of FastWave Medical and Medsiders' top tips to help you navigate towards that goal: https://shorturl.at/6BpXe
The Fierce Healthcare annual Fierce 15
Let's take a look at the companies taking a fresh approach to long-standing problems in healthcare, identifying significant market gaps and bringing next-gen technologies to reimagine the space: https://shorturl.at/BHUAQ
Surgical robotics companies you need to watch
Will the hype ever stop in the robotics space? ... no! These new entrants are at the forefront, introducing cutting-edge technologies and solutions that promise to redefine surgical precision and patient care. Check out the list here: https://shorturl.at/JPi9V
Interested in all things neurology?
Hollie Bevan produces ‘daily neurobites’ – a weekly, sometimes daily, publication of all of the latest updates across the neurotech market. From funding updates, to collaborations, to tech updates, you can find the latest updates here: https://shorturl.at/FigJg
Other news:
First Ascent Biomedical raised $2,000,000
Neuromod Closes €10 Million Financing
Brainomix Completes $18M Series C Investment Round for AI-Powered Imaging Tools
Navina Raises $55M Series C Funding
Life Science
Biotech funding, collaborations and market developments
In February, there was an abundance of funding raised by companies in the Biotech and Biopharma space. Katie Davis produces a monthly newsletter, diving into the companies receiving the funding, collaborations and up-and-coming technological advancements across the market. You can read the February edition here: https://tinyurl.com/3a84m43h
Other news this month:
Proscia raises $50M to expand AI pathology platform amid growing demand for precision diagnostics
Latigo Biotherapeutics, Inc. Closes $150M Series B
Augustine Therapeutics raises oversubscribed EUR 78 million / USD 85 million Series A financing round
Callio Therapeutics Secures $187M to Advance ADCs
Mineralys Therapeutics, Inc. prices $175M stock offering
Curevo Vaccine gets $110M for a shot against Shingrix, gets Moncef Slaoui and Tal Zaks on board
Shoulder Innovations $40 Million (Series E) Raised For Shoulder Replacement Technology
Vivace Therapeutics, Inc. Secures $35 Million in Series D Financing for Cancer Therapies Development
Ataraxis AI raised $20,400,000 / Series A
Surgicure Technologies, Inc. raised $1,785,000
Montara Therapeutics, Inc. Closes $20M Oversubscribed Seed Expansion, Appoints Troy Wilson as Chairman of the Board
Ignota Labs : $6.9 Million (Seed) Raised For AI-Based Drug Turnaround Company
Inceptor Bio raised $21,000,000 / Series A from Kineticos Life Sciences
STEMCELL Technologies raised CA$ 49,900,000 / Grant from Strategic Innovation Fund
Wheeler Bio, Inc. Raises $35M Series A-1 Funding
Myrobalan Therapeutics raised $850,000 / Grant from National Multiple Sclerosis Society (NMSS)
Yaqrit secures NIHR grant for pivotal trials of its liver support device, DIALIVE, for patients with liver failure
Modulo Bio raised $4,800,000 / Seed from Alzheimer's Drug Discovery Foundation
Egle Therapeutics Receives €9.3 Million in State Funding Under the “Innovations in Biotherapies and Bioproduction” Call for Projects from France 2030
Network Biosystems raised $17,000,000
TRIMTECH Therapeutics Limited : $31 Million (Seed) Raised For Advancing Targeted Protein Degradation For Treating Neurodegenerative Diseases
Paradox Immunotherapeutics raised $10,000,000
Osivax €10 Million Raised For Developing Vaccines To Provide Protection Against Respiratory Viruses
Brevel Expands Seed Round to $25M to Advance Microalgae-Based Protein Innovation
Telesis Bio $21 Million Raised For Accelerating Adoption Of Gibson SOLA Technology
Surrozen raised $175,000,000
Luminary Therapeutics, Inc raised $5,800,000
Accro Bioscience raised CN¥100,000,000
GeneMind Biosciences raised CN¥280,000,000
Hememics Biotechnologies, Inc. raised $250,000
Pharma
Halo Pharmaceutical, Inc. raised $25,000,000 / Corporate Round from Noramco
Medicus Pharma Ltd. d. Announces Closing of $4.2 Million Regulation A Offering
Woolsey Pharmaceuticals Completes B Round Extension To Advance Its ALS Program
Morphoceuticals raised $3,500,000 / Seed
Tempero Bio Secures $70 Million Series B Financing to Advance TMP-301 into Phase 2 Trials for Substance Use Disorders
Cyclacel Pharmaceuticals, Inc. raised $1,000,000 / Post Ipo Equity
Forward Pharma A/S raised CN¥100,000,000 / Series Unknown from Optical Valley Venture Capital and Wuhan Hi-Tech
EBRD VC Lends €15 million to Ukraine's pharmaceutical producer YURiA-PHARM LLC
Opus Genetics (formerly Ocuphire Pharma) raised $20,000,000 / Post Ipo Equity from Cam Gallagher and 3 other investors
Revilico Inc. raised $145,000 / Pre Seed from Forum Ventures
MB Therapeutics raised €2,000,000 / Seed from Angels Santé and 4 other investors
Glycovax Pharma raised an undisclosed amount / Grant from Canada Economic Development for Quebec Regions
Tribune Therapeutics raised €23,000,000 / Series A from HealthCap and 6 other investors
Hiring mistakes: Where do they usually start?
Our People Development Manager, Jacqui Columbine has a wealth of recruitment experience and now working on the human resources side, has the ability to understand both the root causes of most hiring mistakes and how Executive Search agencies can help businesses when it comes to refining their hiring strategy and securing top talent more effectively. In this blog piece, Jacqui walks you through the mistakes companies tend to make, and how to combat them: https://tinyurl.com/yc3sdu7b
Looking to partner with an executive search company like ours?
Whatever the size of the business or seniority of the candidate our aim is simple; to ensure our clients build great teams and our candidates secure jobs they love. If you’re a startup looking for talent, or you’d like to learn more about our recruitment services, get in touch with one of our experts here: https://www.inveniagroup.com/book-consultation/
Or, are you an industry expert looking for your next career opportunity? Here are just a few of the roles we’re recruiting for right now. You can find other fantastic opportunities over on our website: www.inveniagroup.com/jobs
Invenia Group connects progressive startup, scale-up and industry-leading firms in the fields of Biopharma, Medtech & Devices, Life Science Tools & Diagnostics and Healthtech with the best talent in your field. Ready to discuss your hiring needs? Get in touch today: info@inveniagroup.com